Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coherus Oncology (CHRS) Non-Current Assets: 2013-2025

Historic Non-Current Assets for Coherus Oncology (CHRS) over the last 11 years, with Sep 2025 value amounting to $55.6 million.

  • Coherus Oncology's Non-Current Assets fell 59.14% to $55.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.6 million, marking a year-over-year decrease of 59.14%. This contributed to the annual value of $107.0 million for FY2024, which is 30.54% down from last year.
  • Per Coherus Oncology's latest filing, its Non-Current Assets stood at $55.6 million for Q3 2025, which was down 6.24% from $59.3 million recorded in Q2 2025.
  • Over the past 5 years, Coherus Oncology's Non-Current Assets peaked at $154.0 million during Q4 2023, and registered a low of $55.6 million during Q3 2025.
  • Its 3-year average for Non-Current Assets is $103.2 million, with a median of $107.0 million in 2024.
  • As far as peak fluctuations go, Coherus Oncology's Non-Current Assets skyrocketed by 57.30% in 2024, and later crashed by 59.14% in 2025.
  • Coherus Oncology's Non-Current Assets (Quarterly) stood at $77.0 million in 2021, then rose by 29.35% to $99.6 million in 2022, then spiked by 54.57% to $154.0 million in 2023, then plummeted by 30.54% to $107.0 million in 2024, then slumped by 59.14% to $55.6 million in 2025.
  • Its Non-Current Assets stands at $55.6 million for Q3 2025, versus $59.3 million for Q2 2025 and $60.9 million for Q1 2025.